Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
InfuSystem Holdings, Inc. (INFU)
NYSE MKT:INFU
RESEARCH TOOLSreports
Holding INFU?
Track your performance easily
Earnings Data
Report Date
Mar 12, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
$0.08Last Year’s EPS
$0.01Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 07, 2024
|% Change Since: 19.05%
|Next Earnings Date:Mar 12, 2025
Earnings Call Sentiment|Positive
The earnings call reflected a positive sentiment with record revenue and strong financial performance. Strategic initiatives and successful debt reduction were offset by challenges in the pain management segment and increased SG&A expenses. Overall, the highlights significantly outweigh the lowlights.Company Guidance
During the InfuSystem Third Quarter 2024 Earnings Call, the company provided guidance indicating strong financial performance and promising growth prospects. InfuSystem reported a record quarterly net revenue of $35.2 million, marking an 11% increase from the previous year and a nearly 5% sequential growth. Adjusted EBITDA margins improved significantly to 22.3%, reflecting increased profitability. The call highlighted the company's strategic initiatives, including new distribution agreements and service contracts, which are expected to bolster future growth. The company paid down $6.4 million in debt and repurchased $700,000 in stock, demonstrating robust cash flow. Looking ahead, InfuSystem reaffirmed its annual guidance, projecting high single-digit net revenue growth and adjusted EBITDA margins in the high teens for the full year 2024.Record Revenue Achievement
The company reported a record net revenue of $35.2 million for Q3 2024, marking a 5% sequential growth and an 11% increase year-over-year.
Strong EBITDA and Cash Flow
Adjusted EBITDA reached $7.9 million or 22% of net revenue, an increase of over $1.7 million from the prior year. Operating cash flow for Q3 2024 was $9.8 million, more than double the amount from the prior year.
Successful Strategic Initiatives
The company launched three new initiatives, including a distribution agreement with Smith & Nephew and a JV with Sanara MedTech for Chemo Mouthpiece, expanding their business and growth potential.
Debt Reduction and Stock Buyback
The company reduced its debt by $6.4 million and repurchased $700,000 worth of stock.
---
INFU Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
INFU Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 07, 2024 | $6.98 | $7.34 | +5.16% |
| Aug 08, 2024 | $5.80 | $6.00 | +3.45% |
| May 09, 2024 | $7.94 | $7.56 | -4.79% |
| Mar 14, 2024 | $9.52 | $9.02 | -5.25% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does InfuSystem Holdings, Inc. (INFU) report earnings?
InfuSystem Holdings, Inc. (INFU) is schdueled to report earning on Mar 12, 2025, TBA Not Confirmed.
What is InfuSystem Holdings, Inc. (INFU) earnings time?
InfuSystem Holdings, Inc. (INFU) earnings time is at Mar 12, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is INFU EPS forecast?
INFU EPS forecast for the fiscal quarter 2024 (Q4) is $0.08.
---